Focal Therapy for Men with Intermediate Risk Prostate Cancer and a Solitary Lesion Should Be the Standard of Care
Dr. Mark Emberton presented “Focal Therapy for Men with Intermediate Risk Prostate Cancer and a...
Read MoreSelect Page
Posted by Mark Emberton, MD, FRCS | Feb 2017
Dr. Mark Emberton presented “Focal Therapy for Men with Intermediate Risk Prostate Cancer and a...
Read MorePosted by Axel Merseburger, MD, PhD | Feb 2017
Dr. Axel Merseburger presented “Predicting Survival of Men with Prostate Cancer after RP” at the...
Read MorePosted by Alexander Lyon, MD, PhD | Feb 2017
Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with...
Read MorePosted by Laurence Klotz, MD, FRCSC | Feb 2017
Laurence Klotz, MD presented “Active Surveillance or: Shrinking the Gray Zone” at the 6th...
Read MorePosted by E. David Crawford, MD | Feb 2017
E. David Crawford, MD presented “ADT: Mechanisms of CV Disease” at the 6th Symposium on the...
Read More